| Stock | Market Cap |
Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
|
0G99.L Oxurion NV
|
2.0 million |
- |
0.00
|
- |
- |
-
|
|
0H7R.L Abeona Therapeutics Inc.
|
12.6 billion |
0.00% |
-
|
- |
- |
-
|
|
0HAV.L Agilent Technologies, Inc.
|
36.8 billion |
0.86% |
28.02
|
4 |
10 |
7%
|
|
0HB0.L Agios Pharmaceuticals, Inc.
|
1.6 billion |
0.00% |
-4.31
|
- |
- |
-
|
|
0HD2.L Alnylam Pharmaceuticals, Inc.
|
43.0 billion |
0.00% |
-43.25
|
- |
- |
-
|
|
0HF9.L Amicus Therapeutics, Inc.
|
4.2 billion |
0.00% |
-14.74
|
- |
- |
-
|
|
0HL9.L Affimed N.V.
|
1540 |
0.00% |
-0.03
|
- |
- |
-
|
|
0HNC.L BioMarin Pharmaceutical Inc.
|
10.9 billion |
0.00% |
278.09
|
- |
- |
-
|
|
0HOJ.L Blueprint Medicines Corporation
|
6.3 billion |
0.00% |
-11.70
|
- |
- |
-
|
|
0HTC.L CARA THERAPEUTICS INC CARA THER
|
22.9 million |
0.00% |
-2.78
|
- |
- |
-
|
|
0I3Q.L Corcept Therapeutics Incorporated
|
3.5 billion |
0.00% |
38.60
|
- |
- |
-
|
|
0I5P.L CYMABAY THERAPEUTICS INC CYMABA
|
21.6 million |
0.00% |
-24.28
|
- |
- |
-
|
|
0IDA.L Dynavax Technologies Corporation
|
1.8 billion |
0.00% |
20.56
|
- |
- |
-
|
|
0IFK.L Editas Medicine, Inc.
|
162.7 million |
0.00% |
-0.70
|
- |
- |
-
|
|
0IJO.L Exelixis, Inc.
|
10.5 billion |
0.00% |
43.96
|
- |
- |
-
|
|
0IL8.L Kyntra Bio, Inc.
|
27.9 million |
0.00% |
-2.28
|
- |
- |
-
|
|
0IV3.L Geron Corporation
|
1.0 billion |
0.00% |
-4.37
|
- |
- |
-
|
|
0J2O.L Halozyme Therapeutics, Inc.
|
7.9 billion |
0.00% |
22.46
|
- |
- |
-
|
|
0J4V.L Heron Therapeutics, Inc.
|
195.1 million |
0.00% |
-0.51
|
- |
- |
-
|
|
0J9P.L Incyte Corporation
|
19.4 billion |
0.00% |
23.17
|
- |
- |
-
|
|
0JAV.L Insmed Incorporated
|
30.5 billion |
0.00% |
-37.41
|
- |
- |
-
|
|
0JBU.L Intellia Therapeutics, Inc.
|
1.4 billion |
0.00% |
-2.54
|
- |
- |
-
|
|
0JDK.L Iovance Biotherapeutics, Inc.
|
1.6 billion |
0.00% |
-1.94
|
- |
- |
-
|
|
0JDM.L IQVIA Holdings Inc.
|
29.6 billion |
0.00% |
31.52
|
- |
- |
-
|
|
0K10.L Mettler-Toledo International Inc.
|
26.5 billion |
0.00% |
37.74
|
- |
- |
-
|
|
0K16.L EVOLUS INC EVOLUS ORD SHS
|
923.2 million |
0.00% |
-11.22
|
- |
- |
-
|
|
0K3W.L Myriad Genetics, Inc.
|
489.9 million |
0.00% |
-48.07
|
- |
- |
-
|
|
0K6R.L Neurocrine Biosciences, Inc.
|
12.9 billion |
0.00% |
178.96
|
- |
- |
-
|
|
0KCC.L ONCOCYTE CORP ONCOCYTE ORD SHS
|
285.9 million |
0.00% |
-3.75
|
- |
- |
-
|
|
0KF3.L Palatin Technologies, Inc.
|
8.0 million |
0.00% |
-52.23
|
- |
- |
-
|
|
0L35.L Sarepta Therapeutics, Inc.
|
1.6 billion |
0.00% |
-3.74
|
- |
- |
-
|
|
0LB2.L Supernus Pharmaceuticals, Inc.
|
1.6 billion |
- |
22.27
|
- |
- |
-
|
|
0LTI.L Waters Corporation
|
18.6 billion |
0.00% |
27.30
|
- |
- |
-
|
|
0M3Q.L Zoetis Inc.
|
59.0 billion |
1.65% |
28.17
|
4 |
10 |
18%
|
|
0NF3.L Paion AG
|
246612 |
- |
-0.10
|
- |
- |
-
|
|
0OCQ.L Transgene SA
|
978942 |
- |
-6.36
|
- |
- |
-
|
|
0Q77.L AB Science S.A.
|
99.2 million |
0.00% |
-4.28
|
- |
- |
-
|
|
0QAV.L Nanobiotix S.A.
|
1.6 billion |
0.00% |
-20.66
|
- |
- |
-
|
|
0QFK.L Celyad Oncology SA
|
11.4 million |
- |
-0.26
|
- |
- |
-
|
|
0QGJ.L Medigene AG
|
1.4 million |
0.00% |
-0.22
|
- |
- |
-
|
|
0QKQ.L MindMaze Therapeutics Holding S.A.
|
9.4 million |
0.00% |
-72.20
|
- |
- |
-
|
|
0QSS.L PHAXIAM Therapeutics S.A.
|
30.9 million |
- |
-2.55
|
- |
- |
-
|
|
0QXX.L Molecular Partners AG
|
189.6 million |
- |
1.19
|
- |
- |
-
|
|
0R0H.L Thermo Fisher Scientific Inc.
|
186.4 billion |
0.34% |
26.15
|
4 |
10 |
14%
|
|
0R1B.L Biogen Inc.
|
27.5 billion |
0.00% |
-
|
- |
- |
-
|
|
0R2M.L Regeneron Pharmaceuticals, Inc.
|
83.6 billion |
0.46% |
11.01
|
4 |
2 |
-
|
|
0R3M.L Vivoryon Therapeutics N.V.
|
41.9 million |
0.00% |
-2.18
|
- |
- |
-
|
|
0R55.L BioSenic S.A.
|
1.7 million |
0.00% |
-0.01
|
- |
- |
-
|
|
0RD1.L Camurus AB (publ)
|
3.1 billion |
0.00% |
-385.98
|
- |
- |
-
|
|
0RDB.L Oryzon Genomics S.A.
|
251.3 million |
0.00% |
-33.01
|
- |
- |
-
|
|
0RNK.L INVENTIVA SA INVENTIVA ORD SHS
|
47.1 million |
0.00% |
-2.34
|
- |
- |
-
|
|
0RQO.L Bonesupport Holding AB (publ)
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
0RU5.L Oncoinvent ASA
|
175.8 million |
0.00% |
-12.27
|
- |
- |
-
|
|
0T6G.L Q32 Bio Inc.
|
58.2 million |
0.00% |
-98.54
|
- |
- |
-
|
|
0UNL.L NEKTAR THERAPEUTICS NEKTAR THER
|
143.3 million |
0.00% |
-0.27
|
- |
- |
-
|
|
0W4N.L Formycon AG
|
172.8 million |
0.00% |
-
|
- |
- |
-
|
|
0Y5E.L Perrigo Company plc
|
1.6 billion |
12.90% |
-13.74
|
4 |
10 |
6%
|
|
0Y5F.L Endo International plc
|
70566 |
- |
-
|
- |
- |
-
|